問卷

TPIDB > Search Result

Search Result

篩選

List

1733Cases

2009-05-30 - 2010-10-31

Phase II/III

  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2009-05-30 - 2010-10-31

Phase II/III

  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2008-10-06 - 2010-03-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2008-10-01 - 2012-12-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
11Sites

Terminated11Sites

2010-06-01 - 2012-10-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2010-05-01 - 2014-02-28

Phase II/III

  • Condition/Disease

  • Test Drug

Participate Sites
17Sites

Terminated17Sites

2009-10-01 - 2014-10-01

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Terminated9Sites

2009-09-01 - 2010-09-30

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2008-07-01 - 2013-12-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Terminated10Sites

2012-05-01 - 2014-05-31

Phase II

A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-04236921 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
  • Condition/Disease

    SYSTEMIC LUPUS ERYTHEMATOSUS

  • Test Drug

    PF-04236921 Powder for Injection, 106 mg/vial

Participate Sites
4Sites

Terminated3Sites

Study ended1Sites